Matches in Wikidata for { <http://www.wikidata.org/entity/Q37698232> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- Q37698232 description "article científic" @default.
- Q37698232 description "article scientifique" @default.
- Q37698232 description "articolo scientifico" @default.
- Q37698232 description "artigo científico" @default.
- Q37698232 description "artículu científicu espublizáu en 2014" @default.
- Q37698232 description "bilimsel makale" @default.
- Q37698232 description "scientific article published on 27 March 2014" @default.
- Q37698232 description "vedecký článok" @default.
- Q37698232 description "vetenskaplig artikel" @default.
- Q37698232 description "videnskabelig artikel" @default.
- Q37698232 description "vědecký článek" @default.
- Q37698232 description "wetenschappelijk artikel" @default.
- Q37698232 description "wissenschaftlicher Artikel" @default.
- Q37698232 description "наукова стаття, опублікована в березні 2014" @default.
- Q37698232 description "научни чланак" @default.
- Q37698232 description "مقالة علمية نشرت في 27 مارس 2014" @default.
- Q37698232 name "Bosutinib in combination with the aromatase inhibitor letrozole: a phase II trial in postmenopausal women evaluating first-line endocrine therapy in locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancer" @default.
- Q37698232 name "Bosutinib in combination with the aromatase inhibitor letrozole: a phase II trial in postmenopausal women evaluating first-line endocrine therapy in locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancer" @default.
- Q37698232 name "Bosutinib in combination with the aromatase inhibitor letrozole: a phase II trial in postmenopausal women evaluating first-line endocrine therapy in locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancer" @default.
- Q37698232 type Item @default.
- Q37698232 label "Bosutinib in combination with the aromatase inhibitor letrozole: a phase II trial in postmenopausal women evaluating first-line endocrine therapy in locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancer" @default.
- Q37698232 label "Bosutinib in combination with the aromatase inhibitor letrozole: a phase II trial in postmenopausal women evaluating first-line endocrine therapy in locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancer" @default.
- Q37698232 label "Bosutinib in combination with the aromatase inhibitor letrozole: a phase II trial in postmenopausal women evaluating first-line endocrine therapy in locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancer" @default.
- Q37698232 prefLabel "Bosutinib in combination with the aromatase inhibitor letrozole: a phase II trial in postmenopausal women evaluating first-line endocrine therapy in locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancer" @default.
- Q37698232 prefLabel "Bosutinib in combination with the aromatase inhibitor letrozole: a phase II trial in postmenopausal women evaluating first-line endocrine therapy in locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancer" @default.
- Q37698232 prefLabel "Bosutinib in combination with the aromatase inhibitor letrozole: a phase II trial in postmenopausal women evaluating first-line endocrine therapy in locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancer" @default.
- Q37698232 P1433 Q37698232-28A90CE2-C676-4EB4-AD08-A9E560656511 @default.
- Q37698232 P1476 Q37698232-4A0EBE6D-8D8D-4D16-9796-3AFC78FDD046 @default.
- Q37698232 P2093 Q37698232-0E6DE6F7-4D59-4AD9-8BCA-EA4AAE99E50E @default.
- Q37698232 P2093 Q37698232-3D5DC884-3181-4E65-A9DB-294793BCF9FB @default.
- Q37698232 P2093 Q37698232-57BD647C-EDB0-4DA3-A1DB-AA71E3CBEB4D @default.
- Q37698232 P2093 Q37698232-5D1C61F1-79A5-4AA8-8586-B698B57F3715 @default.
- Q37698232 P2093 Q37698232-5FBDF5EE-2283-41F8-B492-6D9930F13475 @default.
- Q37698232 P2093 Q37698232-63F86AA6-BD39-40EE-9257-FCD90A5C764F @default.
- Q37698232 P2093 Q37698232-70CFE5BA-3F37-474C-ACA3-F390A8B03A7A @default.
- Q37698232 P2093 Q37698232-75FEA375-5557-4EBC-B700-B8D9A37EA8C8 @default.
- Q37698232 P2093 Q37698232-95EEED9A-119C-4ACD-B6C7-CA2A1AA47D30 @default.
- Q37698232 P2093 Q37698232-C320F056-BDF2-4720-860C-C8E560085206 @default.
- Q37698232 P2093 Q37698232-D56CC22B-83CD-4070-A1EC-4E0C77120C99 @default.
- Q37698232 P2093 Q37698232-D947BA9A-1F4D-434F-8150-203D4C4CE2B5 @default.
- Q37698232 P2093 Q37698232-EF268351-A298-40E6-95C6-92B5FBF36585 @default.
- Q37698232 P304 Q37698232-D6BC1C4C-4AA4-4B2F-A9F5-1A4E511C4EB0 @default.
- Q37698232 P31 Q37698232-4A823270-E192-4BF9-9131-F083EE7B7E3C @default.
- Q37698232 P356 Q37698232-BA6941DC-F8EF-4B0E-93E1-98ADD92EA34E @default.
- Q37698232 P433 Q37698232-64A6B834-CCA9-4416-8254-25D40F45E73E @default.
- Q37698232 P478 Q37698232-C823AE8A-3100-499C-B305-6AF851C21FD6 @default.
- Q37698232 P50 Q37698232-EDA47F4C-3BCD-44F2-BF9B-DC294A9D6579 @default.
- Q37698232 P577 Q37698232-758FB398-820C-44B7-ADCB-B880D8979197 @default.
- Q37698232 P5875 Q37698232-74CE91AE-9B70-42F9-AC06-9FB09318E7BA @default.
- Q37698232 P698 Q37698232-72502230-FCA7-4BB9-BD2B-32B41C387760 @default.
- Q37698232 P921 Q37698232-9A196D5E-7D37-4499-81FC-025F09353410 @default.
- Q37698232 P921 Q37698232-EF61E48F-7674-42E0-B226-5ED4033253BE @default.
- Q37698232 P932 Q37698232-3F03B770-0A17-46F6-80AD-6ABA631C0567 @default.
- Q37698232 P356 THEONCOLOGIST.2014-0021 @default.
- Q37698232 P698 24674874 @default.
- Q37698232 P1433 Q2122327 @default.
- Q37698232 P1476 "Bosutinib in combination with the aromatase inhibitor letrozole: a phase II trial in postmenopausal women evaluating first-line endocrine therapy in locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancer" @default.
- Q37698232 P2093 "Beverly Moy" @default.
- Q37698232 P2093 "Binghe Xu" @default.
- Q37698232 P2093 "Charles Zacharchuk" @default.
- Q37698232 P2093 "Eric Leip" @default.
- Q37698232 P2093 "Fabienne Lebrun" @default.
- Q37698232 P2093 "István Láng" @default.
- Q37698232 P2093 "Kathleen Turnbull" @default.
- Q37698232 P2093 "Ladan Duvillié" @default.
- Q37698232 P2093 "Louis Chow" @default.
- Q37698232 P2093 "Meritxell Bellet" @default.
- Q37698232 P2093 "Nathalie Bardy-Bouxin" @default.
- Q37698232 P2093 "Paul Goss" @default.
- Q37698232 P2093 "Tomasz Sarosiek" @default.
- Q37698232 P304 "348-349" @default.
- Q37698232 P31 Q13442814 @default.
- Q37698232 P356 "10.1634/THEONCOLOGIST.2014-0021" @default.
- Q37698232 P433 "4" @default.
- Q37698232 P478 "19" @default.
- Q37698232 P50 Q90004173 @default.
- Q37698232 P577 "2014-03-27T00:00:00Z" @default.
- Q37698232 P5875 "261184548" @default.
- Q37698232 P698 "24674874" @default.
- Q37698232 P921 Q42824440 @default.
- Q37698232 P921 Q894611 @default.
- Q37698232 P932 "3983830" @default.